Pivotal Therapeutics Inc. (PVTTF)
- Previous Close
0.0018 - Open
0.0018 - Bid --
- Ask --
- Day's Range
0.0018 - 0.0018 - 52 Week Range
0.0018 - 0.0021 - Volume
27,100 - Avg. Volume
0 - Market Cap (intraday)
172,429 - Beta (5Y Monthly) -1,072.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.
www.pivotaltherapeutics.us--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: PVTTF
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PVTTF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PVTTF
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
16.04
Enterprise Value/EBITDA
-2.48
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-85.90%
Return on Equity (ttm)
--
Revenue (ttm)
356.99k
Net Income Avi to Common (ttm)
-3.67M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
24.42k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
690.79k
Company Insights: PVTTF
PVTTF does not have Company Insights